Blood Cancers | Tumor

Obesity May Affect GVHD Risk After Stem Cell Transplant

February 25th 2024, 3:00pm

Video

Patients who were obese tended to have an increased risk of moderate to severe GVHD after undergoing allogeneic hematopoietic cell transplantation, research showed.

Drug Duo Is Efficacious in Treating Posttransplant GVHD

February 24th 2024, 3:00pm

Article

Jakafi plus Rezurock showed promise in treating graft-versus-host disease in patients who underwent undergone allogeneic hematopoietic cell transplantation.

New Drug May Decrease Need for Blood Draws in Patients With PV

February 23rd 2024, 10:00pm

Article

Treatment with rusfertide led to a decrease in the need for blood draws and decreased levels of red blood cells in patients with polycythemia vera.

Early Intro to Carvykti Is ‘Promising’ for Patients With Myeloma

February 23rd 2024, 8:00pm

Article

Most patients with relapsed or refractory multiple myeloma responded to treatment with the CAR-T cell therapy, Carvykti, according to a small study.

The Hardest Decision I Ever Made Because of Cancer

January 30th 2024, 6:00pm

Article

A cancer survivor described the agony of making a life-or-death decision.

Oral Inqovi Safe and Effective Alternative MDS, CMML Treatment

January 29th 2024, 8:00pm

Article

Findings from the ASCERTAIN trial support the use of oral Inqovi for adults with intermediate- and high-risk myelodysplastic syndromes (MDS) such as chronic myelomonocytic leukemia (CMML).

Financial Burdens Harm Quality of Life After Stem Cell Transplants

January 16th 2024, 4:00pm

Article

Financial burdens from medical costs negatively affect quality of life in patients who have received stem cell transplants, recent research showed.

FDA Gives Cancer Drug Updates, Prostate Cancer Trial Enrolls Patients

January 15th 2024, 4:00pm

Podcast

Last week, the FDA provided updates on two cancer therapies. In this episode, we discuss those decisions and more.

Novel Drug Shows 100% Disease Control Rate in WM

January 9th 2024, 4:00pm

Article

A small study of iopofosine I 131 in patients with pretreated Waldenstrom’s macroglobulinemia showed that the disease control rate was 100%.

AML Survivor Tells Patients Waiting for a Stem Cell Donor ‘Don’t Ever Give Up Hope’

October 6th 2023, 7:00pm

Article

For Maggie Cambora, who received a diagnosis of acute myeloid leukemia in 2020, the third potential donor match was the connection that saved her life, she told CURE®.